Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study

Rosalyn Fraser, Alan Yeung, Megan Glancy, Matthew Hickman, Hayley E. Jones, Saket Priyadarshi, Kirsten Horsburgh, Sharon J. Hutchinson, Andrew McAuley*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Downloads (Pure)

Abstract

BACKGROUND AND AIMS: Opioid dependence is associated with an increased risk of suicide. Drug-related mortality among people with opioid dependence in Scotland has more than tripled since 2010; less is known about changes in suicide risk. We aimed to determine if opioid agonist therapy (OAT) in Scotland is protective against suicide and to measure trends in suicide rates in those with opioid dependence over time.

DESIGN: Retrospective cohort study.

SETTING: Scotland, UK.

PARTICIPANTS: 46 453 individuals in Scotland who received at least one prescription for OAT between 2011 and 2020 with over 304 000 person-years (pys) of follow-up.

MEASUREMENTS: We calculated standardised mortality ratios (SMR) using the age- and sex-specific suicide rates in Scotland for years 2011-2020. We fitted multivariable competing-risk regression models to estimate suicide rates by OAT exposure and to estimate trends over time, adjusting for potential confounders.

FINDINGS: There were 575 deaths classed as suicide among the cohort and the overall suicide rate was 1.89 (95% confidence interval [CI] = 1.74-2.05) per 1000 pys. Age and sex SMR for suicide was 7.05 times (95% CI = 6.50-7.65) higher than in the general population. After adjustment, OAT was shown to be highly protective against suicide, with rates more than three times greater (adjusted hazard ratio: 3.07; 95% CI = 2.60-3.62) off OAT compared with on OAT. Suicide rates decreased over time, falling from 2.57 (95% CI = 2.19-3.02) per 1000 pys in 2011-12 to 1.48 (95% CI = 1.21-1.82) in 2019-20.

CONCLUSION: People with opioid dependence in Scotland appear to have a greater risk of suicide than the general population. Treatment is protective, with rates of suicide lower among those on opioid agonist therapy. Suicide rates have decreased over time, during a period in which drug-related death rates in Scotland have risen to globally high levels.

Original languageEnglish
Pages (from-to)276-284
Number of pages9
JournalAddiction
Volume120
Issue number2
Early online date22 Oct 2024
DOIs
Publication statusPublished - Feb 2025

Keywords

  • opiates
  • opioid agonist treatment
  • injecting
  • suicide
  • epidemiology
  • demography
  • modelling
  • Scotland

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Suicide in people prescribed opioid-agonist therapy in Scotland, United Kingdom, 2011–2020: A national retrospective cohort study'. Together they form a unique fingerprint.

Cite this